+1 (502) 904-2126   One Westbrook Corporate Center, Suite 300, Westchester, IL 60154, USA   Site Map
ISSN: 2574 -1241

Impact Factor : 0.548

  Submit Manuscript

Review ArticleOpen Access

Review on Leishmaniasis

Volume 1 - Issue 5

Chiragkumar J Gohil*1 and Jimishaben D Kher2

  • Author Information Open or Close
    • 1Department of pharmaceutical chemistry, Shree Laxminarayan Dev College of Pharmacy, Bharuch, Gujarat, India
    • 2Department of Pharmacology, Shree Dhanvantary Pharmacy College, Surat, Gujarat, India

    *Corresponding author: Chiragkumar J Gohil, Department of Pharmaceutical Chemistry, Shree Laxminarayan Dev College of Pharmacy, Bholav, Bharuch, India

Received: October 16, 2017;   Published: October 24, 2017

DOI: 10.26717/BJSTR.2017.01.000460

Full Text PDF

To view the Full Article   Peer-reviewed Article PDF


epresent a complex of diseases with identical clinical and epidemiological diversity. They depending on clinical symptoms having 3 different species: cutaneous Leishmaniasis, visceral leishmaniasis, mucocutaneous leishmaniasis. The diff stage involvement to produce infection. This infection diagnosis is the depending on the severity of the diease. The cutaneous leishmaniasis is a not more dangerous compare two other types of leishmaniasis. The diff techniques are available for diagnosis purpose. The efficacy of treatment varies with the type of infecting species and resistance pattern. The persistent lack of vaccine against human leishmaniasis is a result of the poor investment in this neglected parasitosis.

Keywords : Leishmaniasis; Parasite; Cutaneous Leishmaniasis; Visceral leishmaniasis; Muco cutaneous leishmaniasis

Abstract| Introduction| Symptoms/Pathology| Life Cycle| Diagnose| Treatment| References|